Effect of the Aspiration Care Bundle on Preventing VAP
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAkdeniz University
About this trial
Many pharmacological and non-pharmacological interventions are used to prevent ventilator-associated pneumonia (VAP). Nurses are directly responsible for implementing non-pharmacological interventions and therefore have an important role in preventing VAP. The most important non-pharmacological nursing interventions to prevent VAP are hand hygiene and oral care. In addition, the head of the bed should be elevated to 30°-45°, head pressure should be monitored, and subglottic aspiration should be performed. Various care packages have been developed to prevent VAP. It has been determined that these care packages reduce the incidence of VAP. The aim of this study was to investigate the effect of the aspiration care package applied in the intensive care unit on preventing the development of ventilator-associated pneumonia, and it was planned as a quasi-experimental study.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients admitted to the pulmonary intensive care unit
Aged 18 years or older
Connected to mechanical ventilation via ETT/TT
Glasgow Coma Scale score: 8 or higher
Disqualifiers
Transferred from the pulmonary intensive care unit to another clinic
Diagnosed with ventilator-associated pneumonia within the first 24 hours
Glasgow Coma Scale score fell below 8 during the study
Deceased at the time of data collection
Trial design
Design model
Single group
Treatments tested in this trial
Aspiration care bundle
Other interventionEvidence-based aspiration care protocol
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: Conrol groupOther 1 intervention
Trial outcomes
Primary outcomes
1
Clinical Pulmonary Infection Score
Clinical Pulmonary Infection Score (CPIS): The CPIS is a clinical scoring system developed to facilitate the diagnosis of ventilator-associated pneumonia (VAP). It combines clinical, radiological, physiological, and microbiological parameters to provide a structured assessment of pulmonary infection in critically ill patients. Parameters evaluated in CPIS: * Temperature (fever or hypothermia) * Leukocyte count (leukocytosis, leukopenia, or normal range) * Tracheal secretions (absence, non-purulent, or purulent) * Arterial oxygenation (PaO₂/FiO₂ ratio) * Chest radiograph findings (infiltrates: absent, diffuse, or localized) * Culture of tracheal aspirate (no growth, light, or heavy growth of pathogenic bacteria) A total score \>6 is commonly considered suggestive of pneumonia.
Time frame
Through study completion, an average of 35 days2
VAP rate monitoring form
Time frame
Through study completion, an average of 35 daysLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: